Page last updated: 2024-11-05

tranexamic acid and Coagulation, Disseminated Intravascular

tranexamic acid has been researched along with Coagulation, Disseminated Intravascular in 50 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research Excerpts

ExcerptRelevanceReference
" To control the hemorrhagic diathesis, we commenced combination therapy for DIC with danaparoid (1,250 Ux2/day, intravenously (IV)) and tranexamic acid (0."7.73Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid. ( Asakura, H; Matsui, O; Nakao, S; Omote, M; Ontachi, Y; Yoshida, T, 2005)
"We clarified the role of fibrinolysis in tissue-factor (TF)-induced rat disseminated intravascular coagulation (DIC) using tranexamic acid (TA)."7.72Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid. ( Asakura, H; Miyamoto, K; Morishita, E; Nakao, S; Sano, Y; Yamazaki, M, 2004)
"We examined the role of coagulation and fibrinolysis in lipopolysaccharide (LPS) induced disseminated intravascular coagulation (DIC) in rats, studying their contribution to fibrin deposition and organ failure in rats with LPS-induced DIC by concurrent administration of low molecular weight heparin (LMWH) with or without tranexamic acid (TA)."7.72Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid. ( Asakura, H; Miyamoto, K; Mizutani, T; Morishita, E; Nakao, S; Omote, M; Ontachi, Y; Sano, Y; Takami, A; Yamazaki, M; Yoshida, T, 2004)
"The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established."5.46Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. ( Adachi, T; Gatate, Y; Kawamura, A; Masaki, N; Namba, T; Sato, A; Yada, H; Yasuda, R, 2017)
"An 82-year-old female with a history of aortic dissection was admitted to our hospital for evaluation of thrombocytopenia and a bleeding tendency."5.39[Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection]. ( Hirano, T; Morikawa, K; Tsuda, H; Tsuji, T; Yamasaki, H, 2013)
"The current therapeutic strategy for disseminated intravascular coagulation (DIC) is limited to control of the underlying disease, and methods for the effective management of DIC have not been established."5.34Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis. ( Asada, N; Asakura, H; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H, 2007)
"Chronic disseminated intravascular coagulation (DIC) is a well-known complication of aortic aneurysm."5.33Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm. ( Arahata, M; Asakura, H; Hayashi, T; Kadohira, Y; Maekawa, M; Minami, S; Morishita, E; Nakao, S; Ontachi, Y; Saito, M; Yamazaki, M, 2005)
"Tranexamic acid was extremely well tolerated in this newborn."5.28Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants. ( Bernstein, M; Hanna, BD, 1989)
" It is not possible to determine whether human activated protein C, recombinant human soluble thrombomodulin, tranexamic acid and dermatan sulphate are effective or harmful for patients presenting with DIC related to acute or chronic leukemia."4.91Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. ( Anand, V; Martí-Carvajal, AJ; Solà, I, 2015)
" It is not possible to determine whether human activated protein C, recombinant human soluble thrombomodulin, tranexamic acid and dermatan sulphate are effective or harmful for patients presenting with DIC related to acute or chronic leukemia."4.87Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. ( Cardona, AF; Martí-Carvajal, AJ; Simancas, D, 2011)
"In cases of placental abruption complicated with disseminated intravascular coagulation, intrapartum administration of coagulation factors can simultaneously promote effective labor and correct hypofibrinogenemia, enabling minimally invasive vaginal delivery."3.80Intrapartum anti-disseminated intravascular coagulation therapy leading to successful vaginal delivery following intrauterine fetal death caused by placental abruption: a case report. ( Baba, K; Era, S; Honda, M; Matsunaga, S; Seki, H; Takai, Y, 2014)
" To control the hemorrhagic diathesis, we commenced combination therapy for DIC with danaparoid (1,250 Ux2/day, intravenously (IV)) and tranexamic acid (0."3.73Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid. ( Asakura, H; Matsui, O; Nakao, S; Omote, M; Ontachi, Y; Yoshida, T, 2005)
" We present a case of postmenopausal bleeding, because of chronic DIC, which resulted from aortic aneurysm and was managed with replacement blood products and tranexamic acid."3.72Postmenopausal bleeding due to chronic DIC. ( Bollapragada, SS; Garg, M; McFarlane, T, 2004)
"We clarified the role of fibrinolysis in tissue-factor (TF)-induced rat disseminated intravascular coagulation (DIC) using tranexamic acid (TA)."3.72Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid. ( Asakura, H; Miyamoto, K; Morishita, E; Nakao, S; Sano, Y; Yamazaki, M, 2004)
"We examined the role of coagulation and fibrinolysis in lipopolysaccharide (LPS) induced disseminated intravascular coagulation (DIC) in rats, studying their contribution to fibrin deposition and organ failure in rats with LPS-induced DIC by concurrent administration of low molecular weight heparin (LMWH) with or without tranexamic acid (TA)."3.72Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid. ( Asakura, H; Miyamoto, K; Mizutani, T; Morishita, E; Nakao, S; Omote, M; Ontachi, Y; Sano, Y; Takami, A; Yamazaki, M; Yoshida, T, 2004)
" Although disseminated intravascular coagulation could not be totally excluded as an alternative mechanism, excessive fibrinolysis was confirmed as the pathogenic cause by the prompt response to the administration of tranexamic acid."3.67Hypofibrinogenemia due to increased fibrinolysis in two patients with acute promyelocytic leukemia. ( Chan, GT; Chan, TK; Chan, V, 1984)
"Whereas in DIC associated with trauma, since balance between coagulation and fibrinolysis collapses drastically in a short period, both anticoagulantion therapy and antifibrinolytic therapy can be utilized depending on clinical conditions."2.53[Anti DIC therapy]. ( Sakamoto, Y; Yahata, M, 2016)
"The optimal treatment of aortic dissection-related DIC remains controversial."1.72Management of disseminated intravascular coagulation after thoracic endovascular aortic repair of type B aortic dissection: a case report. ( Lai, J; Liu, H; Liu, Y, 2022)
"The onset of acute traumatic coagulopathy in trauma patients exacerbates hemorrhaging and dramatically increases mortality."1.48Computational Model for Hyperfibrinolytic Onset of Acute Traumatic Coagulopathy. ( Brummel-Ziedins, K; Buoni, M; Cohen, M; Orfeo, T; Petzold, L; Wu, S; Wu, TB, 2018)
"The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established."1.46Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. ( Adachi, T; Gatate, Y; Kawamura, A; Masaki, N; Namba, T; Sato, A; Yada, H; Yasuda, R, 2017)
"An 82-year-old female with a history of aortic dissection was admitted to our hospital for evaluation of thrombocytopenia and a bleeding tendency."1.39[Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection]. ( Hirano, T; Morikawa, K; Tsuda, H; Tsuji, T; Yamasaki, H, 2013)
"The current therapeutic strategy for disseminated intravascular coagulation (DIC) is limited to control of the underlying disease, and methods for the effective management of DIC have not been established."1.34Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis. ( Asada, N; Asakura, H; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H, 2007)
"Chronic disseminated intravascular coagulation (DIC) is a well-known complication of aortic aneurysm."1.33Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm. ( Arahata, M; Asakura, H; Hayashi, T; Kadohira, Y; Maekawa, M; Minami, S; Morishita, E; Nakao, S; Ontachi, Y; Saito, M; Yamazaki, M, 2005)
"Tranexamic acid was extremely well tolerated in this newborn."1.28Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants. ( Bernstein, M; Hanna, BD, 1989)
"Fibrinolysis was inhibited by intravenous injection of AMCA and thrombin was infused into the jugular vein, giving rise to heavy intravascular fibrin deposition in the kidneys."1.25Protection against the impairment of renal function after intravascular coagulation in the rat kidney by increased ingestion of sodium chloride. ( Gerdin, B; Rammer, L, 1975)

Research

Studies (50)

TimeframeStudies, this research(%)All Research%
pre-199015 (30.00)18.7374
1990's8 (16.00)18.2507
2000's11 (22.00)29.6817
2010's13 (26.00)24.3611
2020's3 (6.00)2.80

Authors

AuthorsStudies
Liu, H1
Liu, Y1
Lai, J1
Benhamou, D1
Keita, H1
Ducloy-Bouthors, AS1
Yamada, S1
Asakura, H8
Gatate, Y1
Masaki, N1
Sato, A1
Yasuda, R1
Namba, T1
Yada, H1
Kawamura, A1
Adachi, T1
Hattesen, AL1
Berg, HK1
Folkersen, L1
Hvas, AM1
Wu, TB1
Wu, S1
Buoni, M1
Orfeo, T1
Brummel-Ziedins, K1
Cohen, M1
Petzold, L1
Tsuji, T1
Morikawa, K1
Hirano, T1
Yamasaki, H1
Tsuda, H1
Engelbrecht, S1
Wood, EM1
Cole-Sinclair, MF1
Cole, E1
Davenport, R1
Schlitter, MC1
Rühl, H1
Thiesler, T1
Penner, AH1
Berens, C1
Wolf, D1
Mayer, K1
Schwameis, M1
Thaler, J1
Schober, A1
Schörgenhofer, C1
Kulinna-Cosentini, C1
Laggner, A1
Röggla, M1
Jilma, B1
Honda, M1
Matsunaga, S1
Era, S1
Takai, Y1
Baba, K1
Seki, H1
Martí-Carvajal, AJ2
Anand, V1
Solà, I1
Revollo, JY1
Cuffy, MC1
Witte, DP1
Paterno, F1
Alloway, RR1
Woodle, ES1
Yahata, M1
Sakamoto, Y1
Kimura, SI1
Odawara, J1
Aoki, T1
Yamakura, M1
Takeuchi, M2
Watanabe, Y1
Matsue, K2
Colucci, G1
Alberio, L1
Jahns, M1
Keller, P1
Steiner, S1
Rüsges-Wolter, I1
Lämmle, B1
Simancas, D1
Cardona, AF1
Bollapragada, SS1
Garg, M1
McFarlane, T1
Sano, Y3
Yamazaki, M5
Morishita, E5
Miyamoto, K4
Nakao, S6
Omote, M4
Yoshida, T4
Ontachi, Y5
Mizutani, T2
Kaneda, M1
Takami, A2
Arahata, M2
Kadohira, Y2
Maekawa, M2
Hayashi, T2
Saito, M1
Minami, S1
Matsui, O1
Martínez Rodríguez, E1
Mato, M1
Otero, J1
Ferri, JR1
Gonzálvez, A1
Torres, LM1
Takahashi, Y1
Koseki, M1
Asada, N1
Uryu, H1
Sabato, AF1
Foti, A1
De Cosmo, G1
Bondoli, A1
Chan, TK1
Chan, GT1
Chan, V1
Ståhl, E1
Rammer, L2
Uchiba, M1
Okajima, K1
Murakami, K1
Okabe, H1
Okamoto, S2
Okada, Y2
Katsaros, D1
Grundfest-Broniatowski, S1
Meijer, K1
Smid, WM1
Geerards, S1
van der Meer, J1
Cremer, H1
Schulte am Esch, J1
Pannewig, R1
Etzel, S1
Kondo, M1
Yoshikawa, T1
Takemura, S1
Yokoe, N1
Kawai, K1
Masuda, M1
Sakuragawa, N1
Takahashi, K1
Hoshiyama, M1
Jimbo, C1
Matsuoka, M1
Prentice, CR1
Gerdin, B1
Tomikawa, M1
Wanaka, K1
Hijikata-Okunomiya, A1
Katsuura, Y1
Sugawara, T1
Okuda, M1
Yamaguchi, Y1
Endo, K1
Yoshinaga, K1
Takada, A1
Takada, Y1
Mori, T1
Sakaguchi, S1
Carthew, P1
Dorman, BM1
Edwards, RE1
Albronda, T1
Gökemeyer, JD1
van Haeflen, TW1
Tomeoku, M1
Nakase, T1
Morita, K1
Katou, M1
Eriksson, M1
Saldeen, T2
Hanna, BD1
Bernstein, M1
Páramo, JA1
Cuesta, B1
Aranda, A1
Rocha, E1
Wegener, T1
Wallin, R1
Bottari, M1
Donati, L1
Gagnatelli, G1

Reviews

7 reviews available for tranexamic acid and Coagulation, Disseminated Intravascular

ArticleYear
Coagulation changes and thromboembolic risk in COVID-19 obstetric patients.
    Anaesthesia, critical care & pain medicine, 2020, Volume: 39, Issue:3

    Topics: Anticoagulants; Autoantibodies; Betacoronavirus; Blood Proteins; Cerebrovascular Disorders; Contrain

2020
Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
    International journal of hematology, 2021, Volume: 113, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Anticoagulants; Antifibrinolytic

2021
[Drowning-induced hyperfibrinolytic disseminated intravascular coagulation].
    Ugeskrift for laeger, 2017, Aug-28, Volume: 179, Issue:35

    Topics: Antifibrinolytic Agents; Disseminated Intravascular Coagulation; Humans; Near Drowning; Thrombelasto

2017
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.
    The Cochrane database of systematic reviews, 2015, Jun-24, Issue:6

    Topics: Acute Disease; Anticoagulants; Chronic Disease; Dermatan Sulfate; Disseminated Intravascular Coagula

2015
[Anti DIC therapy].
    Nihon rinsho. Japanese journal of clinical medicine, 2016, Volume: 74, Issue:2

    Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coa

2016
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.
    The Cochrane database of systematic reviews, 2011, Jun-15, Issue:6

    Topics: Acute Disease; Anticoagulants; Chronic Disease; Dermatan Sulfate; Disseminated Intravascular Coagula

2011
Indications for antifibrinolytic therapy.
    Thrombosis et diathesis haemorrhagica, 1975, Dec-15, Volume: 34, Issue:3

    Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Coagulation Disorders; Disseminated Intrav

1975

Other Studies

43 other studies available for tranexamic acid and Coagulation, Disseminated Intravascular

ArticleYear
Management of disseminated intravascular coagulation after thoracic endovascular aortic repair of type B aortic dissection: a case report.
    BMC cardiovascular disorders, 2022, 07-18, Volume: 22, Issue:1

    Topics: Aged; Anticoagulants; Aortic Aneurysm, Thoracic; Aortic Dissection; Blood Vessel Prosthesis Implanta

2022
Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years.
    Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:8

    Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Aortic Dissection; Chronic Disease; Disseminated Int

2017
Computational Model for Hyperfibrinolytic Onset of Acute Traumatic Coagulopathy.
    Annals of biomedical engineering, 2018, Volume: 46, Issue:8

    Topics: Acute Disease; Disseminated Intravascular Coagulation; Fibrinolysis; Humans; Models, Cardiovascular;

2018
[Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2013, Volume: 54, Issue:8

    Topics: Aged, 80 and over; Antifibrinolytic Agents; Aortic Dissection; Chronic Disease; Disseminated Intrava

2013
Clinical transfusion practice update: haemovigilance, complications, patient blood management and national standards.
    The Medical journal of Australia, 2013, Sep-16, Volume: 199, Issue:6

    Topics: Acute Lung Injury; Anticoagulants; Antifibrinolytic Agents; Australia; Blood Transfusion; Clinical P

2013
Early tranexamic acid use in trauma haemorrhage: why do we give it and which patients benefit most?
    International emergency nursing, 2015, Volume: 23, Issue:1

    Topics: Antifibrinolytic Agents; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Tra

2015
Paraneoplastic disseminated intravascular coagulation caused by splenic littoral cell angioma.
    Annals of hematology, 2014, Volume: 93, Issue:10

    Topics: Blood Component Transfusion; Chest Pain; Combined Modality Therapy; Disseminated Intravascular Coagu

2014
Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:5

    Topics: Adenocarcinoma; Aged; Anemia; Antifibrinolytic Agents; Antineoplastic Combined Chemotherapy Protocol

2014
Intrapartum anti-disseminated intravascular coagulation therapy leading to successful vaginal delivery following intrauterine fetal death caused by placental abruption: a case report.
    Journal of medical case reports, 2014, Dec-23, Volume: 8

    Topics: Abruptio Placentae; Adult; Antifibrinolytic Agents; Coagulants; Delivery, Obstetric; Disseminated In

2014
Case Report: Hemolytic Anemia Following Deceased Donor Renal Transplantation Associated With Tranexamic Acid Administration for Disseminated Intravascular Coagulation.
    Transplantation proceedings, 2015, Volume: 47, Issue:7

    Topics: Aged; Anemia, Hemolytic; Antifibrinolytic Agents; Diabetes Mellitus, Type 2; Disseminated Intravascu

2015
Use of tranexamic acid for disseminated intravascular coagulation with excessive fibrinolysis associated with aortic dissection in a patient with chronic renal failure.
    International journal of hematology, 2009, Volume: 89, Issue:4

    Topics: Aged; Aortic Aneurysm; Disseminated Intravascular Coagulation; Fibrinolysis; Humans; Kidney Failure,

2009
Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis.
    Thrombosis and haemostasis, 2009, Volume: 102, Issue:6

    Topics: alpha-2-Antiplasmin; Amyloidosis; Antifibrinolytic Agents; Disseminated Intravascular Coagulation; F

2009
Postmenopausal bleeding due to chronic DIC.
    European journal of obstetrics, gynecology, and reproductive biology, 2004, Jan-15, Volume: 112, Issue:1

    Topics: Aged; Aortic Aneurysm; Blood Transfusion; Chronic Disease; Disseminated Intravascular Coagulation; F

2004
Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid.
    Haematologica, 2004, Volume: 89, Issue:6

    Topics: Animals; Disseminated Intravascular Coagulation; Fibrinolysis; Hemostasis; Male; Rats; Rats, Wistar;

2004
Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.
    International journal of hematology, 2004, Volume: 79, Issue:4

    Topics: Animals; Antifibrinolytic Agents; Biomarkers; Blood Coagulation; Disseminated Intravascular Coagulat

2004
Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.
    Intensive care medicine, 2004, Volume: 30, Issue:10

    Topics: Animals; Anticoagulants; Blood Coagulation; Disseminated Intravascular Coagulation; Drug Interaction

2004
Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.
    Circulation journal : official journal of the Japanese Circulation Society, 2005, Volume: 69, Issue:9

    Topics: Anticoagulants; Antifibrinolytic Agents; Aortic Aneurysm, Abdominal; Chondroitin Sulfates; Dermatan

2005
Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid.
    Haematologica, 2005, Volume: 90 Suppl

    Topics: Adult; Antifibrinolytic Agents; Blood Proteins; Chondroitin Sulfates; Dermatan Sulfate; Disseminated

2005
[Hemostatic drugs in a patient with antiphospholipid syndrome and clinically significant perioperative bleeding].
    Revista espanola de anestesiologia y reanimacion, 2006, Volume: 53, Issue:3

    Topics: Adult; Aminocaproic Acid; Antiphospholipid Syndrome; Aprotinin; Blood Coagulation Tests; Blood Loss,

2006
No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
    Critical care medicine, 2006, Volume: 34, Issue:10

    Topics: Animals; Antifibrinolytic Agents; Cytokines; Disseminated Intravascular Coagulation; Hemostatics; In

2006
Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis.
    International journal of hematology, 2007, Volume: 86, Issue:5

    Topics: Acute Disease; Adult; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antineoplastic Agents; Antithrom

2007
[Coagulative changes in gynecologic surgery. Clinical and therapeutic evaluation].
    Recenti progressi in medicina, 1980, Volume: 68, Issue:4

    Topics: Adult; Aged; Anesthesia; Aprotinin; Blood Coagulation Disorders; Disseminated Intravascular Coagulat

1980
Hypofibrinogenemia due to increased fibrinolysis in two patients with acute promyelocytic leukemia.
    Australian and New Zealand journal of medicine, 1984, Volume: 14, Issue:3

    Topics: Adult; Afibrinogenemia; Antibiotics, Antineoplastic; Blood Coagulation Tests; Diagnosis, Differentia

1984
Effect of unilateral ureteral occlusion on fibrin deposition in the kidney and renal blood flow during intravascular coagulation in rat.
    Scandinavian journal of urology and nephrology, 1983, Volume: 17, Issue:2

    Topics: Animals; Disseminated Intravascular Coagulation; Female; Fibrin; Kidney; Kidney Glomerulus; Rats; Ra

1983
Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
    Thrombosis and haemostasis, 1997, Volume: 78, Issue:4

    Topics: Amino Acid Chloromethyl Ketones; Animals; Binding Sites; Bronchoalveolar Lavage Fluid; Capillary Per

1997
Successful management of visceral Klippel-Trenaunay-Weber syndrome with the antifibrinolytic agent tranexamic acid (cyclocapron): a case report.
    The American surgeon, 1998, Volume: 64, Issue:4

    Topics: Adult; Antifibrinolytic Agents; Blood Coagulation Tests; Colon, Sigmoid; Disseminated Intravascular

1998
Hyperfibrinogenolysis in disseminated adenocarcinoma.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1998, Volume: 9, Issue:3

    Topics: Adenocarcinoma; Adult; Afibrinogenemia; alpha-2-Antiplasmin; Antifibrinolytic Agents; Brain Ischemia

1998
[Experimental observations in rabbits with pulmonary hyalin membranes (author's transl)].
    Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1978, Volume: 62

    Topics: Animals; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinol

1978
Hemorrhagic necrosis of the intestinal mucosa associated with disseminated intravascular coagulation.
    Digestion, 1978, Volume: 17, Issue:1

    Topics: Animals; Blood Coagulation Factors; Complement System Proteins; Disseminated Intravascular Coagulati

1978
Pathologic cells as procoagulant substance of disseminated intravascular coagulation syndrome in acute promyelocytic leukemia.
    Thrombosis research, 1976, Volume: 8, Issue:3

    Topics: Acute Disease; Animals; Aprotinin; Blood Coagulation; Chromatography, Gel; Disseminated Intravascula

1976
Protection against the impairment of renal function after intravascular coagulation in the rat kidney by increased ingestion of sodium chloride.
    Nephron, 1975, Volume: 14, Issue:6

    Topics: Acute Kidney Injury; Animals; Diet; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinol

1975
Patho-physiological studies on lactic acid-induced pulmonary thrombosis in rat. I. Effect of heparin, acetylsalicylic acid, urokinase and tranexamic acid.
    Thrombosis et diathesis haemorrhagica, 1975, Sep-30, Volume: 34, Issue:1

    Topics: Animals; Aspirin; Blood Coagulation; Disseminated Intravascular Coagulation; Fibrinolysis; Heparin;

1975
A finding of highly selective synthetic inhibitor of plasma kallikrein; its action to bradykinin generation, intrinsic coagulation and experimental DIC.
    Agents and actions. Supplements, 1992, Volume: 38 ( Pt 1)

    Topics: Animals; Blood Coagulation; Bradykinin; Disease Models, Animal; Disseminated Intravascular Coagulati

1992
Successful treatment with tranexamic acid for severe bleeding in acute promyelocytic leukemia.
    Acta haematologica, 1992, Volume: 87, Issue:1-2

    Topics: Adult; Disseminated Intravascular Coagulation; Female; Hemorrhage; Humans; Leukemia, Promyelocytic,

1992
Prevention of severe bleeding by tranexamic acid in a patient with disseminated intravascular coagulation.
    Thrombosis research, 1990, Apr-15, Volume: 58, Issue:2

    Topics: Aged; alpha-Macroglobulins; Aorta, Abdominal; Aortic Aneurysm; Cyclohexanecarboxylic Acids; Dissemin

1990
Increased susceptibility of aged rats to haemorrhage and intravascular hypercoagulation following endotoxin administered in a generalized Shwartzman regime.
    Journal of comparative pathology, 1991, Volume: 105, Issue:3

    Topics: Aging; Animals; Depression, Chemical; Disease Susceptibility; Disseminated Intravascular Coagulation

1991
Transient acute renal failure due to tranexaminic acid therapy for diffuse intravascular coagulation.
    The Netherlands journal of medicine, 1991, Volume: 39, Issue:1-2

    Topics: Acute Kidney Injury; Aged; Disseminated Intravascular Coagulation; Humans; Male; Tranexamic Acid

1991
[Chronic disseminated intravascular coagulation due to abdominal true aneurysm in two cases--effect of anti-platelet and anti-fibrinolytic therapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:12

    Topics: Aged; Aorta, Abdominal; Aortic Aneurysm; Chronic Disease; Cyclohexanecarboxylic Acids; Disseminated

1989
Effects of an inhibitor of angiotensin converting enzyme (Captopril) on pulmonary and renal insufficiency due to intravascular coagulation in the rat.
    International journal of microcirculation, clinical and experimental, 1989, Volume: 8, Issue:3

    Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disseminated Intr

1989
Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants.
    The American journal of pediatric hematology/oncology, 1989,Summer, Volume: 11, Issue:2

    Topics: Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Fema

1989
[Treatment of severe coagulopathy in the Kasabach-Merritt syndrome].
    Sangre, 1986, Volume: 31, Issue:1

    Topics: Adult; Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Female; Hemangioma; Huma

1986
Effect of N-acetylcysteine on fibrin deposition in the rat lung due to intravascular coagulation.
    Upsala journal of medical sciences, 1986, Volume: 91, Issue:1

    Topics: Acetylcysteine; Animals; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Humans; Iodine

1986
[Disseminated intravascular coagulation as a complication of shock].
    Atti della Accademia medica lombarda, 1973, Volume: 28, Issue:1-4

    Topics: Aminocaproic Acid; Aprotinin; Disseminated Intravascular Coagulation; Heparin; Humans; Shock; Tranex

1973